Request Deal Involvement

Qiming Ventures led a $106m Series D round in Asieris Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

V-CAPITAL

bidder

V-CAPITAL

HOMSUN CAPITAL

bidder

HOMSUN CAPITAL

TRIWISE CAPITAL

bidder

TRIWISE CAPITAL

HAOSHUO ZHIER FUND

bidder

HAOSHUO ZHIER FUND

HENGXU CAPITAL

bidder

HENGXU CAPITAL

ASIERIS PHARMACEUTICALS

target

ASIERIS PHARMACEUTICALS

QIMING VENTURE PARTNERS

bidder

QIMING VENTURE PARTNERS

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

bidder

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

GOPHER ASSET MANAGEMENT

bidder

GOPHER ASSET MANAGEMENT

C&D CORPORATION

bidder

C&D CORPORATION

IN CAPITAL

bidder

IN CAPITAL

IFSC

bidder

IFSC

YUNFENG CAPITAL

bidder

YUNFENG CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Qiming Ventures led a $106m Series D round in Asieris Pharmaceuticals.